Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients.

Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY 14223 , United States.
Journal of Neuroimmunology (Impact Factor: 2.79). 11/2008; 205(1-2):142-7. DOI: 10.1016/j.jneuroim.2008.09.008
Source: PubMed

ABSTRACT The study is aimed to determine the role of quercetin (3,3'4',5,7-pentahydroxy flavone), alone and in combination with human interferon-beta (IFN-beta), in modulating the immune response(s) of peripheral blood mononuclear cells (PBMC) isolated from multiple sclerosis (MS) patients and from normal healthy subjects. PBMC proliferation in the presence or absence of these drugs was determined and the production of proinflammatory cytokines (IL-1beta, TNF-alpha), and the ratio of cell migration mediator MMP-9, and its inhibitor, TIMP-1 were assessed in the culture supernatants. Quercetin reduced, in a dose-dependent manner, the proliferation of PBMC and modulated the level of IL-1beta and TNF-alpha released by PBMC in the culture supernatants. Quercetin reduced the MMP-9/TIMP-1 ratio via lowering MMP-9 production. Quercetin, when combined with IFN-beta, had additive effects in modulating TNF-alpha and MMP-9. These immunomodulatory responses to quercetin were similar between MS patients and healthy control (HC) subjects.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This investigation aimed to evaluate the in vitro and in vivo antitumor potential of a Moroccan propolis extracts. For in vitro assays, three mammalian tumor cell lines were used: BSR (hamster renal adenocarcinoma), Hep-2 (human laryngeal carcinoma) and P815 (murin mastocytoma). The propolis ethanolic extract as well as the ethyl acetate extract, exert an in vitro cytotoxic activity in dose-dependent manner. The IC50 values were ranging from 15 µg/mL to 38 µg/mL. This activity depends not only on the extract's chemical composition (analysed by HPLC/ESI-MS), but also on the target tumor cells. Interestingly, the cytotoxic effect of these extracts on the normal human peripheral blood mononuclear cells (PBMC) was weak when compared to that induced on tumor cells. On the other hand, oral route treatment of P815 tumor-bearing mice (DBA2/P815) with propolis ethanolic extract (5 mg per mouse every fourth day, five times for group A, and 2.5 mg per mouse every fourth day, five times for group B) significantly reduced the tumor volume (1.2 cm3 for group A and 2.7 cm3 for group B at the 22nd day after tumor graft). These effects are statistically significant as compared to those obtained with the control untreated mice (tumor volume 3.5 cm3 at day 22).
    Revista Brasileira de Farmacognosia 06/2012; 22(3):558-567. · 0.80 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The present study was conducted to describe the effects of quercetin dietary supplementation, at levels of 0.5 and 1 g/kg of feed, on growth performance, internal organ weights, meat quality, and meat oxidative stability during storage of broiler chickens reared from hatching to 42 d of age. Body weight and cumulative feed intake were not affected by quercetin supplementation (P > 0.05). However, poorer feed conversion ratio values were obtained with increasing levels of dietary quercetin (P-linear < 0.05). Relative heart weight was significantly higher for chickens that were given quercetin in comparison with the controls (P < 0.05). The rest of the internal organ weights measured (liver, spleen, and fat pad) and meat quality traits were not affected by dietary supplementation with quercetin, except for meat lightness and redness. Meat oxidative stability, expressed as nanograms of malondialdehyde per gram of meat, was improved (P < 0.05) during refrigerated storage for 3 and 9 d, when birds were fed quercetin at a level of 1 g/kg of feed. It is concluded that the incorporation of quercetin in broiler diets could prolong meat shelf life by reducing the rate of lipid oxidation, and increase relative heart weight, potentially contributing to improved animal health.
    Poultry Science 08/2014; 93:1957-1962. · 1.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aging leads to numerous transitions in brain physiology including synaptic dysfunction and disturbances in cognition and memory. With a few clinically relevant drugs, a substantial portion of aging population at risk for age-related neurodegenerative disorders require nutritional intervention. Dietary intake of polyphenols is known to attenuate oxidative stress and reduce the risk for related neurodegenerative diseases such as Alzheimer's disease (AD), stroke, multiple sclerosis (MS), Parkinson's disease (PD), and Huntington's disease (HD). Polyphenols exhibit strong potential to address the etiology of neurological disorders as they attenuate their complex physiology by modulating several therapeutic targets at once. Firstly, we review the advances in the therapeutic role of polyphenols in cell and animal models of AD, PD, MS, and HD and activation of drug targets for controlling pathological manifestations. Secondly, we present principle pathways in which polyphenol intake translates into therapeutic outcomes. In particular, signaling pathways like PPAR, Nrf2, STAT, HIF, and MAPK along with modulation of immune response by polyphenols are discussed. Although current polyphenol researches have limited impact on clinical practice, they have strong evidence and testable hypothesis to contribute clinical advances and drug discovery towards age-related neurological disorders.
    Oxidative Medicine and Cellular Longevity 01/2013; 2013:891748.